Tag: CDK4/6 inhibitor

Ribociclib Future Outlook 2025: Upcoming Trials, New Uses & Market Trends

Explore ribociclib's future: new trials, potential cancer uses, market outlook, and how it stacks up against rival CDK4/6 inhibitors.